There was a broad range of signal intensities with a statistically significant loss of STAG2 expression in the tumor tissue (Wilcoxon rank test) and complete absence of STAG2 staining observed in 15 (4.3%) patients (Additional files 4 and 5). The gene discussed is STAG2; the disease is neoplasm.